Grantham, Mayo, Van Otterloo & Co (GMO)’s Stride LRN Stock Holding History
Bought
Maintained
Sold
Other funds holding LRN
VPM
VCM
FCM
IC
Grantham, Mayo, Van Otterloo & Co (GMO)'s LRN Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Stride (LRN) stake by 9.3% in Q1 2026, buying an estimated $62K and bringing the position to 8,946 shares worth $789K. The position accounts for ﹤0.01% of the portfolio, ranked #527.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LRN in Q4 2017 and has held it in 17 quarters since. The position peaked at $14.4M in Q1 2019. 419 funds tracked by Wall St. Rank hold LRN as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 8,946 shares of Stride worth $789K as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 764 Stride shares in Q1 2026, an estimated $62K.
- Stride made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #527 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Stride in Q4 2017 and has held it in 17 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Stride position peaked at $14.4M in Q1 2019.
- 419 funds tracked by Wall St. Rank held Stride as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.